scholarly journals Endocrine Status in Patients with Optic Nerve Hypoplasia: Relationship to Midline Central Nervous System Abnormalities and Appearance of the Hypothalamic-Pituitary Axis on Magnetic Resonance Imaging

2003 ◽  
Vol 88 (11) ◽  
pp. 5281-5286 ◽  
Author(s):  
N. H. Birkebæk ◽  
L. Patel ◽  
N. B. Wright ◽  
J. R. Grigg ◽  
S. Sinha ◽  
...  

Abstract We here: 1) describe the phenotypic spectrum, including magnetic resonance imaging (MRI) appearances of the pituitary stalk and anterior and posterior pituitary [H-P (hypothalamic-pituitary) axis], in children with optic nerve hypoplasia (ONH) with or without an abnormal septum pellucidum (SP); and 2) define endocrine dysfunction according to the MRI findings. Medical records of 55 children with ONH who had been assessed by ophthalmology and endocrine services were reviewed. All had MRI of the brain and H-P axis. Forty-nine percent of the ONH patients had an abnormal SP on MRI, and 64% had a H-P axis abnormality. Twenty-seven patients (49%) had endocrine dysfunction, and 23 of these had H-P axis abnormality. The frequency of endocrinopathy was higher in patients with an abnormal SP (56%) than a normal SP (39%). Patients were divided into four groups based on SP and H-P axis appearance: 1) both normal; 2) abnormal SP and normal H-P axis; 3) normal SP and abnormal H-P axis; and 4) both abnormal. The frequency of multiple pituitary hormone deficiency was highest (56%) in group 4, lower (35%) in group 3, and even lower (22%) in group 2. Precocious puberty was most common in group 2. None of the patients in group 1 had endocrine dysfunction. Thus, SP and H-P axis appearances on MRI can be used to predict the likely spectrum of endocrinopathy.

Author(s):  
Samantha D. Sagaser ◽  
John C. Benson ◽  
Laurence J. Eckel ◽  
Sasha A. Mansukhani ◽  
Launia White ◽  
...  

1996 ◽  
Vol 122 (5) ◽  
pp. 717-723 ◽  
Author(s):  
JEFFREY A. SORKIN ◽  
PATRICIA C. DAVIS ◽  
LILLIAN R. MEACHAM ◽  
JOHN S. PARKS ◽  
ARLENE V. DRACK ◽  
...  

Author(s):  
Phoebe D. Lenhart ◽  
Nilesh K. Desai ◽  
Beau B. Bruce ◽  
Amy K. Hutchinson ◽  
Scott R. Lambert

2005 ◽  
Vol 90 (6) ◽  
pp. 3350-3359 ◽  
Author(s):  
David A. van Tijn ◽  
Jan J. M. de Vijlder ◽  
Bernard Verbeeten ◽  
Paul H. Verkerk ◽  
Thomas Vulsma

Due to the high frequency of concurrent pituitary hormone deficiencies, congenital hypothyroidism (CH) of central origin (CH-C) is a life-threatening disorder. Yet only a minority of these patients are detected by neonatal CH screening programs worldwide. We conducted a prospective multicenter study involving a 2-yr cohort of neonatally diagnosed CH-C patients to determine whether a T4-TSH-based neonatal CH screening protocol extended with T4 binding globulin determinations improves early detection of CH-C and to assess the extent of pituitary hormone deficiency among the identified CH-C patients. In all infants with screening results indicative of CH-C, the functional integrity of the hypothalamo-hypophyseal system was investigated by dynamic tests; the anatomical integrity was investigated by magnetic resonance imaging. Initial test results were evaluated after 5 yr of follow-up. Among 385,000 infants screened over the 2-yr period, 19 cases of permanent CH-C were detected (prevalence, 1:20,263; 95% confidence interval, 1:12,976 to 1:33,654), representing 13.5% of all detected cases of permanent CH. The majority (78%) had multiple pituitary hormone deficiency, whereas 53% had pituitary malformations on magnetic resonance imaging. We conclude that infants with CH-C can very well be detected by neonatal screening. The estimated prevalence and the severity of pituitary dysfunction of this treatable disorder call for explicit attention for this entity of CH in neonatal screening programs worldwide.


2014 ◽  
Vol 158 (6) ◽  
pp. 1164-1171.e2 ◽  
Author(s):  
Phoebe D. Lenhart ◽  
Nilesh K. Desai ◽  
Beau B. Bruce ◽  
Amy K. Hutchinson ◽  
Scott R. Lambert

Sign in / Sign up

Export Citation Format

Share Document